advertisement

---

Talcott KE 9

Showing records 1 to 9 | Display all abstracts from Talcott KE

112920 Effect of Prefilled vs Vial-Drawn Syringes on Sustained Increases in Intraocular Pressure in Patients Treated With Aflibercept
Russell MW
Journal of vitreoretinal diseases 2023; 7: 498-503

---

113131 Impact of Dyslipidemia Medications on the Prevalence of Diabetic Retinopathy Among a Large US Cohort
Chadalavada SH; Shaia JK
Ophthalmic surgery, lasers & imaging retina 2023; 54: 626-633

---

112920 Effect of Prefilled vs Vial-Drawn Syringes on Sustained Increases in Intraocular Pressure in Patients Treated With Aflibercept
Chalasani M; Rana N
Journal of vitreoretinal diseases 2023; 7: 498-503

---

113131 Impact of Dyslipidemia Medications on the Prevalence of Diabetic Retinopathy Among a Large US Cohort
Russell MW
Ophthalmic surgery, lasers & imaging retina 2023; 54: 626-633

---

112920 Effect of Prefilled vs Vial-Drawn Syringes on Sustained Increases in Intraocular Pressure in Patients Treated With Aflibercept
Muste JC
Journal of vitreoretinal diseases 2023; 7: 498-503

---

113131 Impact of Dyslipidemia Medications on the Prevalence of Diabetic Retinopathy Among a Large US Cohort
Talcott KE
Ophthalmic surgery, lasers & imaging retina 2023; 54: 626-633

---

112920 Effect of Prefilled vs Vial-Drawn Syringes on Sustained Increases in Intraocular Pressure in Patients Treated With Aflibercept
Muste JC; Rachitskaya AV
Journal of vitreoretinal diseases 2023; 7: 498-503

---

113131 Impact of Dyslipidemia Medications on the Prevalence of Diabetic Retinopathy Among a Large US Cohort
Singh RP
Ophthalmic surgery, lasers & imaging retina 2023; 54: 626-633

---

112920 Effect of Prefilled vs Vial-Drawn Syringes on Sustained Increases in Intraocular Pressure in Patients Treated With Aflibercept
Talcott KE; Singh RP; Sharma S
Journal of vitreoretinal diseases 2023; 7: 498-503

---